Australia markets close in 2 hours 18 minutes

AbCellera Biologics Inc. (ABCL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
8.30+0.27 (+3.36%)
At close: 04:00PM EDT
8.21 -0.09 (-1.08%)
After hours: 07:57PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2022)Next qtr. (Sep 2022)Current year (2022)Next year (2023)
No. of analysts7777
Avg. Estimate0.05-0.070.47-0.48
Low estimate-0.15-0.150.12-0.69
High estimate0.360.010.92-0.29
Year ago EPS-0.01-0.080.480.47
Revenue estimateCurrent qtr. (Jun 2022)Next qtr. (Sep 2022)Current year (2022)Next year (2023)
No. of analysts7787
Avg. Estimate81.69M28.75M438.18M83.74M
Low estimate7.79M10.27M347.84M49.48M
High estimate227.51M57.62M660.95M128.07M
Year ago sales71.51MN/A375.2M438.18M
Sales growth (year/est)14.20%N/A16.80%-80.90%
Earnings history29/06/202129/09/202130/12/202130/03/2022
Est. EPS0.08-0.050.190.38
Actual EPS-0.01-0.080.190.54
Difference-0.09-0.0300.16
Surprise %-112.50%-60.00%0.00%42.10%
EPS trendCurrent qtr. (Jun 2022)Next qtr. (Sep 2022)Current year (2022)Next year (2023)
Current estimate0.05-0.070.47-0.48
7 days ago0.05-0.060.31-0.41
30 days ago0.09-0.070.23-0.34
60 days ago0.09-0.070.23-0.34
90 days ago0.07-0.050.02-0.35
EPS revisionsCurrent qtr. (Jun 2022)Next qtr. (Sep 2022)Current year (2022)Next year (2023)
Up last 7 days235N/A
Up last 30 days237N/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 days4312
Growth estimatesABCLIndustrySector(s)S&P 500
Current qtr.600.00%N/AN/AN/A
Next qtr.12.50%N/AN/AN/A
Current year-2.10%N/AN/AN/A
Next year-202.10%N/AN/AN/A
Next 5 years (per annum)10.00%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A